Learn more

NANJING MINGDE NEW DRUG RES AND DEV CO LTD

Overview
  • Total Patents
    14
  • GoodIP Patent Rank
    145,527
About

NANJING MINGDE NEW DRUG RES AND DEV CO LTD has a total of 14 patent applications. Its first patent ever was published in 2013. It filed its patents most often in China and Taiwan. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are FATHEREE PAUL R, PLIANT THERAPEUTICS INC and WANBURY LTD.

Patent filings in countries

World map showing NANJING MINGDE NEW DRUG RES AND DEV CO LTDs patent filings in countries
# Country Total Patents
#1 China 10
#2 Taiwan 4

Patent filings per year

Chart showing NANJING MINGDE NEW DRUG RES AND DEV CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Chen Shuhui 8
#2 Li Jian 6
#3 Chen Shu-Hui 4
#4 He Haiying 3
#5 Ding Zhaozhong 3
#6 Yao Yuan-Shan 2
#7 Li Ning 2
#8 Wu Ling-Yun 2
#9 Chen Zhao-Guo 2
#10 Li Peng 2

Latest patents

Publication Filing date Title
CN105732635A Toll-like receptor 7 agonist
TW201605834A Imidazole derivative used as antiviral agent and use thereof in preparation of medicament
CN105085512A Enteric virus 71 (EV71)-resistant thiadiazolidine derivatives
CN105503903A Preparation method of benzoxazoloxazone compound and intermediate and crystal form
CN105153164A Dihydropyrimidocyclic derivative taken as HBV inhibitor
CN105085515A Hydrazide compound as blood coagulation factor Xa inhibitor
CN105085478A Isoquinoline sulfanilamide derivatives, and pharmaceutical composition and pharmaceutical application thereof
CN105085525A Isoquinoline sulfonyl derivatives as RHO kinases inhibitor
CN104974161A 4H-pyrazolo[1,5-[alpha]]benzimidazole compound analogue as PARP inhibitor
CN104693211A Imidazole derivative as antiviral agent and pharmaceutical application thereof
CN104418866A DGAT1 inhibitor, and preparation method and application thereof